Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 16 of 16 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham | |
Company Alcon Research LLC | Activity: Research and Development | Company Description Alcon discovers, develops and commercializes first-in-class therapies for the treatment of patients with glaucoma, dry eye, retinal diseases and other diseases of the eye. | Location Durham | |
Company Altis BioSystems Inc. | Activity: Research and Development | Company Description Altis Biosystems has developed a patented stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. | Location Durham | |
Company Appealing Products Inc. | Activity: Research and Development | Company Description Appealing Products develops products for forensics and personal protection from toxic materials such as inorganics, gases and poisons in foods, animal feeds and liquids. | Location Raleigh | |
Company Balanced Pharma Inc. | Activity: Research and Development | Company Description Balanced Pharma is developing pH-balanced (buffered) injectable anesthetic drugs with enhanced usability qualities for use in dental and dermatological surgery. | Location Cornelius | |
Company BioIVT | Activity: Research and Development | Company Description BioIVT provides biological specimens, specializing in control and disease state human and animal tissues. This site develops and commercializes cell-based drug toxicity-testing products for pharmaceutical development, based on hepatocyte technologies. | Location Durham | |
Company BioRxn LLC | Activity: Research and Development | Company Description BioRxn develops NMR-based metabolomic technology, including bioreactor and artificial liver systems, for non-invasive monitoring of metabolic biomarkers. BioRxn also provides conventional metabolomic services. | Location Chapel Hill | |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville | |
Company GEM Tox Labs | Activity: Research and Development | Company Description GEM Tox Labs conducts research focused on the role of MicroRNA molecules in cancer. | Location Greenville | |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park | |
Company IndiOmics LLC | Activity: Research and Development | Company Description Indiomics uses machine learning and protein biomarker expression levels to identify connections between human cells and common chemical exposures. | Location Wilmington | |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham | |
Company Parion Sciences Inc. | Activity: Research and Development | Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory diseases. | Location Durham | |
Company SeaTox Research Inc. | Activity: Research and Development | Company Description SeaTox Research develops bioassays for the detection of marine toxins and conducts pharmaceutical development through bioprospecting. | Location Wilmington | |
Company SonoVol Inc | Activity: Research and Development | Company Description SonoVol has developed a preclinical imaging technology that can be applied to in vivo models that researchers use to evaluate the efficacy and toxicity of new drugs before they enter clinical trials. | Location Durham | |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill |